Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0761
D

Medication Labeling Deficiency

Yeadon, Pennsylvania Survey Completed on 01-15-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that medications were properly and accurately labeled in accordance with currently accepted professional principles. During an observation of medication administration, it was found that a nurse administered a nasal spray to a resident using a bottle labeled with another resident's name. Specifically, the bottle of Fluticasone nasal spray used for Resident R42 was labeled with Resident R78's name, despite being administered to Resident R42. This discrepancy was confirmed during an interview with the nurse at the time of the observation. Resident R42 was admitted to the facility with a diagnosis of acute sinusitis and had a physician's order for Fluticasone Propionate Nasal Suspension for allergy relief. Resident R78, who had been discharged from the facility, had a similar order for the same medication, which was discontinued upon discharge. The facility's policy requires that medications be administered safely and as prescribed, with verification of the resident's identity and medication label checks. However, these procedures were not followed, leading to the administration of medication with incorrect labeling.

Plan Of Correction

Resident R42's fluticasone propionate was placed in the correct box. A house-wide audit was completed to ensure that medications were properly and accurately labeled in accordance with currently accepted professional standards. Licensed staff will be in-serviced to ensure that medications are properly and accurately labeled in accordance with currently accepted professional principles. The Director of Nursing/Designee will conduct a random audit of 5 residents' medications to ensure that they are properly and accurately labeled in accordance with currently accepted professional principles. This audit will be completed weekly for four weeks and then monthly for three months. This plan of correction will be monitored at the monthly Quality Assurance Performance Improvement meeting until such time consistent substantial compliance has been met.

An unhandled error has occurred. Reload 🗙